SR One For Profit
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies.
Invests into
%20.jpg)
.jpg)
Funding Status:
N/A
Industry:
Finance & Banking
Estimated Revenue:
$8.1 Million
Acquisitions Number:
NA
Number Of Exists:
53
Headquarters:
Cambridge, Massachusetts, United States
Investor Type:
Corporate Venture Capital
Employee Number:
1-10
Investors Number:
NA
Investment Stage:
Series A, Series C
Zip:
NA
Founded Date:
1985-01-01